Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Publication Number 20180319887

US 20180319887 A1
Patent NumberUS 10308714 B2
Application Number16024340
Filled DateJun 29, 2018
Priority DateMay 15, 2012
Publication DateNov 8, 2018
Original AssigneeBristol Myers Squibb
Current AssigneeBristol Myers Squibb
Inventor/ApplicantsJohn P. Cogswell
Xi-Tao Wang
Jon M. Wigginton
Maria Jure-Kunkel
Stacie M. Goldberg
Ashok K. Gupta
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.